FORGE THERAPEUTICS INC
Biotech · Acquired
Novel small-molecule LpxC inhibitors targeting Gram-negative bacterial lipid A biosynthesis
forgetherapeutics.com →- Grants
- $300K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 27
- 5 granted · 22 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel small molecule inhibitors of LpxC for multi-drug resistant Gram-negative bacteria. | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel small molecule inhibitors of LpxC for multi-drug resistant Gram-negative bacteria. | $150,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2083 | Daedalus Systems Inc./de | — | $11M |
| 2084 | Reclaim Pharmaceutical Waste Management, LLC | — | — |
| 2085 | Medium Corp | — | $31M |
| 2086 | FORGE THERAPEUTICS INC | — | — |
| 2087 | CryptoMedix, Inc. | — | $100K |
| 2088 | hC Bioscience | — | $12M |
| 2089 | Eden Food International Inc. | — | $13M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Antibacterial Compoundsgranted
- Lpxc Inhibitor, Formulations, And Uses Thereofapplication
- Antibacterial Compoundsgranted
- Substituted Pyrimidines For Treating Bacterial Infectionsapplication
- Substituted Pyrimidines For Treating Bacterial Infectionsgranted
- Pyrone Based Compounds For Treating Bacterial Infectionsgranted
- Hydroxypyrimidinone And Hydroxypyrimidinone Based Compounds For Treating Bacterial Infectionsgranted
- Antibacterial Compound, Methods Of Making, And Formulations Thereofapplication
- Antibacterial Compoundsapplication
- Antibacterial Compoundsapplication
- Antibacterial Compoundsapplication
- Antibacterial Compoundsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.